Correlation Between Apexigen and In8bio
Can any of the company-specific risk be diversified away by investing in both Apexigen and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apexigen and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apexigen and In8bio Inc, you can compare the effects of market volatilities on Apexigen and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apexigen with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apexigen and In8bio.
Diversification Opportunities for Apexigen and In8bio
Good diversification
The 3 months correlation between Apexigen and In8bio is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Apexigen and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Apexigen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apexigen are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Apexigen i.e., Apexigen and In8bio go up and down completely randomly.
Pair Corralation between Apexigen and In8bio
If you would invest 28.00 in In8bio Inc on September 1, 2024 and sell it today you would earn a total of 2.00 from holding In8bio Inc or generate 7.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Apexigen vs. In8bio Inc
Performance |
| Timeline |
| Apexigen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| In8bio Inc |
Apexigen and In8bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apexigen and In8bio
The main advantage of trading using opposite Apexigen and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apexigen position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.| Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
| In8bio vs. Tff Pharmaceuticals | In8bio vs. Eliem Therapeutics | In8bio vs. Inhibrx | In8bio vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |